Aurora Science

Aurora Science is a Milan-based biotech investment company that backs independent, entrepreneurial biotechnology start-ups across Europe, selecting for high therapeutic potential. Its remit sits between venture investment and industrial development: capital is combined with an industrial approach intended to move projects from basic research through to the development of medicines. The firm's stated foundation is the partners' experience in pharmaceutical research, technology transfer and drug development, and it was launched as a partnership between Rottapharm Biotech, Italfarmaco and AurorA-TT.

The investment model pairs financing with hands-on support toward industrial development. Technical areas of activity include biotechnology, pharmaceutical research, technology transfer, drug development, therapeutic innovation and research and development. Portfolio companies named to date are Peptomyc, which Aurora Science has advanced toward industrial development, and InteRNA Technologies, in which Aurora Science led an investment round in 2021.

Geographic presence is centred on Italy, with Milan as the base and Europe as the target market for deal sourcing. Aurora Science does not disclose fund size, team size or founding year. Its focus on a small number of therapeutically oriented assets, taken forward toward industrial readiness, distinguishes it from generalist early-stage investors in the European life sciences market.